Clinical Trial Update: Chymase Angiotensin-(1-12) Axis In Hypertensive Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update related to the chymase Angiotensin-(1-12) axis in hypertensive disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Snippet

Sponsor: Trinity Hypertension & Metabolic Research Institute | Conditions: Hypertension | Phase 4 | Status: UNKNOWN